Algoclinic
ActiveSummary
Algoclinic has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,101 and a net result of €2,101. Its solvency ranks better than 20% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. Wouter Van den Berge
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meer bestuurders,natuurlijke personen, algemene vergadering kan mandaat steeds hernieuwen” (deed in Dutch)1 more provision on this in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Op naam, 50” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Friday of March at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Ontbinding op elk moment door algemene vergadering, vereisten statutenwijziging” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Ontbinding en sluiting vereffening in één akte mogelijk, artikel 2:80 WVV” (deed in Dutch)“Beroep op artsen voor zaken persoonlijke levenssfeer patiënten en/of beroepsgeheim aandeelhouders, algemene vergadering kan te allen tijde…” (deed in Dutch)